DR. JESS D SALINAS MD NPI 1487751632

NPI Details

DR. Jess D Salinas, MD is an interventional pain medicine pain medicine in Lake Mary, FL with 27 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. DR. Jess D Salinas, MD NPI is 1487751632. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2692 W LAKE MARY BLVD
LAKE MARY, FL
ZIP 32746-535
Phone: (407) 936-2070
Fax: (407) 936-2071

The NPI 1487751632 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Destruction of nerves supplying joint between spine and pelvis using imaging guidance (HCPCS:64625)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Testing for presence of drug, read by direct observation (HCPCS:80305)

The enumeration date for this NPI number is 9/20/2006 and was last updated on 1/28/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.